4
Changes in Ownership
INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-17-000008
Chief Executive Officer gave up 70,392 shares (to pay taxes)
- Chief Executive Officer acquired 197,079 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kim Jong Joseph · Chief Executive Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-03-09 | Exercise or conversion : show line 1 in the form | +57,334 | 2,021,944 | D | ||
| 2017-03-09 | Shares withheld for taxes : show line 2 in the form | −17,787 | $6.61 | $117,572 | 2,004,157 | D |
| 2017-03-10 | Exercise or conversion : show line 3 in the form | +139,745 | 2,143,902 | D | ||
| 2017-03-10 | Shares withheld for taxes : show line 4 in the form | −52,605 | $6.68 | $351,401 | 2,091,297 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2017-03-09 | Exercise or conversion : show line 5 in the form Restricted Stock Unit | −57,334 | 57,334 | 114,666 | D | ||||
| 2017-03-10 | Grant or award : show line 6 in the form Common Stock Option | +43,150 | $6.68 | $288,242 | $6.68 | 2027-03-10 | 43,150 | 43,150 | D |
| 2017-03-10 | Grant or award : show line 7 in the form Restricted Stock Unit | +317,100 | 317,100 | 317,100 | D |
Loading xslF345X03/wf-form4_148944129682642.xml…